STEVE PHILLIPS
Direktor/Vorstandsmitglied bei Wellth, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark Capone | M | 61 |
Nephrosant, Inc.
 Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 3 Jahre |
| Matthew Loper | M | - |
Wellth, Inc.
 Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | 10 Jahre |
| Alec Zopf | M | - |
Wellth, Inc.
Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | 10 Jahre |
| Minnie Sarwal | M | - |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 7 Jahre |
| Brad Marzullo | M | - |
Davita Venture Group
 Davita Venture Group Investment ManagersFinance DaVita Venture Group (DaVita Venture Group) is a venture capital firm subsidiary of DaVita Inc. founded in 2019. The firm is headquartered in Denver, Colorado. | 4 Jahre |
| Michael B. Laskoff | M | - |
Wellth, Inc.
Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | - |
| Jordan Gray | M | - |
Wellth, Inc.
Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | - |
| Manish Agarwal | M | 50 |
Wellth, Inc.
Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | - |
| Yixuan Ma | M | - |
Wellth, Inc.
Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | 8 Jahre |
| Yuanling Yuan | F | - |
Wellth, Inc.
Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | 1 Jahre |
| Jane Rho | F | - |
Davita Venture Group
Davita Venture Group Investment ManagersFinance DaVita Venture Group (DaVita Venture Group) is a venture capital firm subsidiary of DaVita Inc. founded in 2019. The firm is headquartered in Denver, Colorado. | 4 Jahre |
| Joshua Yang | M | - |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 7 Jahre |
| Tom Musgrave | M | - |
Davita Venture Group
Davita Venture Group Investment ManagersFinance DaVita Venture Group (DaVita Venture Group) is a venture capital firm subsidiary of DaVita Inc. founded in 2019. The firm is headquartered in Denver, Colorado. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Lee Roy McCracken | M | 66 |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | - |
| Krishnan Mahesh /davita/ | - | - |
Davita Venture Group
Davita Venture Group Investment ManagersFinance DaVita Venture Group (DaVita Venture Group) is a venture capital firm subsidiary of DaVita Inc. founded in 2019. The firm is headquartered in Denver, Colorado. | 4 Jahre |
| Michele A. Colucci | F | - |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 3 Jahre |
| Daniel Spiegel | M | - |
Davita Venture Group
Davita Venture Group Investment ManagersFinance DaVita Venture Group (DaVita Venture Group) is a venture capital firm subsidiary of DaVita Inc. founded in 2019. The firm is headquartered in Denver, Colorado. | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 17 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- STEVE PHILLIPS
- Persönliches Netzwerk
